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Available online 7 August 2011Stress can enhance and inhibit nociception depending on the situation. Thus, simply
shifting the context from the elevated plus maze (EPM) which has been shown to produce
stress-induced antinociception to a different environment could produce drastic and rapid
changes in nociception. The present experiment tested this hypothesis by assessing
nociception in rats and mice during and immediately after removal from the maze.
Experiment 1 found hyperalgesia in female and male rats tested on the hot plate
immediately after exposure to the elevated plus maze. This hyperalgesia occurred with or
without the added stress of a hind paw formalin injection and regardless of whether rats
were exposed to an EPM with open (oEPM) or enclosed (eEPM) arms despite a clear
antinociceptive effect while on the oEPM. Experiment 2 showed a similar shift from
antinociception to nociception on the formalin test in mice immediately after removing
them from the EPM. These data demonstrate that a mild stressor such as the EPM can
produce both antinociception and hyperalgesia depending on the context. This shift from
antinociception to hyperalgesia occurs rapidly and is evident in mice, male and female rats,
and with the hot plate and formalin tests.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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Rat and mouse1. Introduction
Exposure to dangerous conditions (commonly referred to as
stressors) result in a group of organized behavioral, autonomic
and hormonal responses that increase the chance of survival
(Van de Kar and Blair, 1999). In general, these reactions area, Faculdade de Ciências
.
.L. Nunes-de-Souza).
aze; eEPM, Enclosed eleva
posed to the open elevate
exposed to the open eleva
the Elsevier OA license.accompanied by pain inhibition (Fanselow, 1991; Fardin et al.,
1984; Kelly, 1986; Terman et al., 1984; Watkins and Mayer,
1982). For instance, rats exposed to a cat display species-
specific defensive behaviors and antinociception (Fanselow,
1991; Lester and Fanselow, 1985). Environmentally induced
antinociception also has been shown to occur followingFarmacêuticas-UNESP, Rod. Araraquara-Jaú, km 01, 14801-902,
ted plusmaze; EPM, elevated plusmaze; G-G, group exposed to the
d plus maze for 10 min (25–35 min) and returned to the glass box
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(e.g., Canto-de-Souza et al., 1997; Costa et al., 2005; Kelly, 1982;
Miczek et al., 1982; Rodgers et al., 1990; Rodgers and Hendrie,
1983; Rodgers and Randall, 1986; Rodgers and Shepherd, 1989;
Terman et al., 1984).
Subtle aversive stimuli such as exposure to the elevated
plus-maze (EPM) have also been shown to produce antinocicep-
tion (e.g., Lee and Rodgers, 1990, 1991; Nunes-de-Souza et al.,
2000; Rodgers et al., 1992; Taukulis and Goggin, 1990). The EPM
(Pellow et al., 1985) or elevated X maze (Handley and Mithani,
1984) was originally validated to study anxiety-like behaviors in
rats and mice (Lister, 1987; Stephens et al., 1986). This test is
based on the natural aversion of rodents to open spaces andhas
been used to study anxiety and its modulation by drug
treatment. The maze has recently been modified to show that
antinociception is caused by exposure to the open (oEPM; an
elevated platform with four open arms), not the enclosed arms
(Cornélio and Nunes-de-Souza, 2009; Mendes-Gomes et al.,
2011; Mendes-Gomes and Nunes-de-Souza, 2005, 2009). The
EPM isamuchmorenatural stimulus than footshock andseems
particularly well suited to assess the rapid changes in nocicep-
tion that probably occurs with subtle changes in natural
aversive situations.
Although numerous studies have shown that threatening
situations induce pain inhibition in a variety of animal models
(Canto-de-Souza et al., 1997; Fanselow, 1991; Lester and Fanse-
low, 1985; Miczek et al., 1982; Rodgers et al., 1990; Rodgers and
Hendrie, 1983; Rodgers andRandall, 1986, Rodgers andShepherd,
1989), conflicting pre-clinical and clinical results involving the
interaction of fear/anxiety and nociceptive responses suggest
that this relationship may not be so simple. For example, it has
been shown that anxiety can exacerbate pain symptoms (Kainet
al., 2000; Rhudy and Meagher, 2000). A significant number of
animal studies have shown that stressful stimuli induce
hyperalgesia. Rats exposed to relatively mild non-noxious
stressors, such as vibration (Devall et al., 2009), a novel
environment (Vidal and Jacob, 1986), gently holding by the
nape of the neck (Vidal and Jacob, 1986) or exposing rats to
repeated stressful stimuli can produce hyperalgesia (Quintero et
al., 2000). Although exposure to the EPM seems like a relatively
mild stressor, clear antinociceptive effects occur while in the
maze (Cornélio andNunes-de-Souza, 2009;Mendes-Gomeset al.,
2011;Mendes-GomesandNunes-de-Souza, 2005, 2009).Whether
those antinociceptive effects persist when rodents are removed
from the maze is not known. The objective of the present study
was to test the hypothesis that antinociceptionwill disappear as
soonas theanimal is removed fromtheEPMexposure.Moreover,
given that the responsiveness to noxious stimuli and to opioid
drugs varies with sex and strain (Craft, 2003b; Mogil et al., 2000),
we also investigated whether exposure to the EPM produces
differential nociceptive responses in male and female rats.Fig. 1 – Hyperalgesia in male and female rats following
exposure to the EPM. Hot plate latency (n=8–9) was reduced
in rats previously exposed to the eEPM or oEPM for 10 min
compared to rats remaining in their home cage. Columns
represent means (±S.E.M). *p<0.05 vs home cage.2. Results
2.1. Experiment 1: effect of EPMexposure onhotplate latency
The primary objective of this experimentwas to determine the
duration of an antinociceptive response following the expo-
sure of a rat to the EPM. This was assessed in rats with andwithout formalin administration into the hind paw and in
male and female rats. A number of studies report sex-related
differences in nociceptive responses in humans and animals
(for review see Craft, 2003a, 2007; Hurley and Adams, 2008;
Wiesenfeld-Hallin, 2005), but relatively few studies have
assessed the effects of sex in environmentally induced
antinociception.
Rats were exposed to the enclosed or open EPM for 10min
and then removed to test nociception using the hot plate test. A
decrease in hot plate latency was evident immediately after
removing rats from the EPM compared to control rats not
exposed to the EPM (Fig. 1). This hyperalgesia was evident in
both male and female rats and independent of whether they
were exposed to the enclosed or open EPM. Two-way ANOVA
revealed significant effects for place of exposure [F (2, 43)=9.02,
P<0.05], but not for sex [F (1, 43)=0.02, P>0.05] or an interaction
between these factors [F (2, 43)=0.08, P>0.05]. Newman Keuls
test indicated that eEPM and oEPM groups had lower response
latencies than rats kept in the home cage (p<0.05).
Previous experiments used the formalin test to assess
antinociception while rats were in the EPM (Cornélio and
Nunes-de-Souza, 2009). Thus, a few rats were tested as
described above except that formalin was injected in the right
hind paw prior to exposure to the EPM. Administration of
formalin caused comparable nociception in all rats prior to
exposure to the EPMas indicated by a non-significant difference
in theamountof time licking thehindpaw [F (2, 10)=0.6,P>0.05].
Rats placed in theoEPMduring the secondphase of the formalin
test spent almost no time licking the paw compared to rats not
placed in the EPM (Fig. 2). The time spent licking the formalin
injected paw in rats exposed to the eEPM was intermediate
between these two groups as has been reported previously
(Cornélio and Nunes-de-Souza, 2009; Mendes-Gomes et al.,
2011; Mendes-Gomes and Nunes-de-Souza, 2005, 2009). This
Fig. 2 – Antinociception occurs during exposure to the oEPM.
Time spent licking the formalin (formaldehyde 0.925%)
injected pawduring the second phase of formalin test in rats
(n=4–5/group) kept in the Plexiglas box (no maze) or
exposed to the eEPM or oEPM for 10 min. Columns represent
means (±S.E.M).
Fig. 3 – Formalin administration does not alter post-EPM
hyperalgesia. Hot plate latency (n=4–5) of rats previously
injected with formalin (formaldehyde 0.925%) into the right
hind paw and kept in the Plexiglas box (no maze) or exposed
to the eEPM or oEPM for 10 min. Hot plate latency was
assessed immediately after the EPM exposure. Columns
represent means (±S.E.M). *p<0.05 vs No maze and eEPM.
Fig. 4 – Antinociception is limited to EPM exposure in mice.
Time spent licking the right hind paw during the second
phase (25–55 min) of the formalin test in mice (n=9). G-G:
glass box exposure until the end of the test; oEPM-G: open
EPM exposure for 10 min (25–35 min) and returned to the
glass cage until the end of the test (55 min); oEPM-oEPM: open
EPM exposure until the end of the test. *p<0.05 vs G-G.
#p<0.05 vs 25–35 min.
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hyperalgesia when they were placed on the hot plate immedi-
ately after EPM exposure (H=5.51, P=0.05). Post hoc compari-
sons revealed that oEPM-exposed rats displayed lower hot plate
latency than No Maze- and eEPM-exposed rats (Fig. 3).
2.2. Experiment 2: assessment of formalin nociception in
mice following EPM exposure
The objective of this experiment was to determine whether
EPM-induced hyperalgesia generalizes across species (rat to
mouse) and nociceptive test (hot plate to formalin test).
Injection of formalin into the mouse hind paw produced a
comparable time licking the paw (18–23 s) during the first
phase (0–5 min) of the test [F (4, 38)=1.28, P>0.05]. This lack of
effect confirmed the sample homogeneity of mice kept in the
glass box.
The amount of time spent licking the hind paw during the
second phase of the formalin test was determined by the
environment. Control mice remaining in the glass box spent
much more time licking the hind paw than mice in the oEPM
(Fig. 4). This antinociception was reversed immediately in mice
removed from the oEPM to the glass box compared to mice
remaining in theoEPM.Two-wayANOVAfor repeatedmeasures
revealed significant effects for place of exposure [F (4, 38)=12.63,
P<0.05], time [F (2, 76)=6.68, P<0.05] and the interaction
between these two factors [F (8, 76)=11.54, P<0.05]. For the
interval 25–35min, one way ANOVA followed by Duncan's test
revealed that mice in the oEPM spent significantly less time
licking the injected paw than the control group in the glass box
(p<0.05). Antinociceptionwasmaintained bymice remaining in
the oEPM during the interval 35–45min, but was instantly
reversed in mice moved from the oEPM to the glass box. This
shift to the glass box led to hyperalgesia during the 45–55min
interval compared to mice maintained in the glass box
throughout (p<0.05).3. Discussion
The present data demonstrate that the antinociception
produced by exposure to the EPM is specific to the stressful
environment and shifts to hyperalgesia upon removal. This
shift from antinociception to hyperalgesia is immediate,
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whether nociception is assessed with the hot plate or
formalin tests.
Post-maze hyperalgesia contrasts with the pronounced
antinociception in rats (Cornélio and Nunes-de-Souza, 2009)
and mice (Mendes-Gomes et al., 2011; Mendes-Gomes and
Nunes-de-Souza, 2005, 2009) exposed to the oEPM. In those
studies nociceptionwas assessed bymeasuring the time spent
licking the paw injected with formalin during, rather than
after maze exposure. In contrast, the antinociception pro-
duced by footshock persists well beyond the period of
exposure to the environment in which the shock was
administered (Terman et al., 1984). Thus, both severe and
mild stress produce antinociception, but the duration of that
antinociception depends on the stressor. Exposure to other
mild non-noxious stressors such as inescapable holding,
novel environment or vibration evokes an immediate and
transient hyperalgesia (Devall et al., 2009; Vidal and Jacob,
1982). However, despite studies showing that threatening
situations induce pain inhibition in a variety of animalmodels
(Canto-de-Souza et al., 1997; Fanselow, 1991; Lester and
Fanselow, 1985; Miczek et al., 1982; Rodgers et al., 1990;
Rodgers and Hendrie, 1983; Rodgers and Randall, 1986,
Rodgers and Shepherd, 1989), conflicting pre-clinical and
clinical results involving the interaction of fear/anxiety and
nociceptive responses suggest that anxiety can exacerbate
pain symptoms (Kain et al., 2000; Rhudy andMeagher, 2000). In
this context it is necessary to highlight that the results
obtained in this study cannot be generalized to other
ethological animal models of anxiety/fear since currently
there is separation of anxiety disorders in different diagnostic
categories. Then, different animal models of anxiety/fear
could model a different subtype of anxiety disorder implicat-
ing that this hyperalgesia caused by changing the context at
the end of the test may not be valid for all tests. More studies
are necessary to investigate this question.
Although the antinociceptive effects of the oEPM are much
greater than that produced by exposure to the eEPM (Cornélio
and Nunes-de-Souza, 2009; Mendes-Gomes et al., 2011;
Mendes-Gomes and Nunes-de-Souza, 2005, 2009), hyperalge-
sia was evident following exposure to either maze. In this
context, it seems that exposure to the eEPM may be a form of
novelty stress. Supporting this assumption are the results
showing that mice exposed to the eEPM display higher plasma
corticosterone levels (a biological marker of stress) than mice
from control groups not exposed to the EPM (Mendes-Gomes
et al., 2009). It has been shown that rats exposed to a new
environment for 5 min display hyperalgesia as assessed by tail
shock in addition to other signs of novelty stress such as
exploration, rearing, grooming and defecation (Vidal and
Jacob, 1982).
Whether a stressor induces antinociception or hyperalge-
sia depends on many factors such as the type of stressor, the
pain test (Vidal and Jacob, 1986), repetition and/or intensity of
the stimulus, or the time elapsed post-stress (Imbe et al., 2006;
Langford et al., 2011). For example, acute exposure to
emotionally arousing non-noxious stress, such as inescapable
holding, novel environments or vibration produces an imme-
diate and transient hyperalgesia (Vidal and Jacob, 1982, 1986).
Hyperalgesia also occurs as a result of chronic stress inducedby repeated exposure to a cold environment (Omiya et al.,
2000), restraint (Gamaro et al., 1998) or forced swim (Quintero
et al., 2000, Quintero et al., 2003). Chronic stress-induced
hyperalgesia generally lasts longer than that induced by acute
stress. The short-lived hyperalgesia in the present study
suggests that hyperalgesia is caused by residual stress
resulting from the acute exposure of rats to non-noxious
stress (eEPM or oEPM).
Regarding sex-related differences, several studies with
humans have reported sex-related differences in pain per-
ception, from laboratory experiments to epidemiological
studies of clinical conditions (for review see Craft, 2007).
Clinical studies reveal that women report more severe pain,
more frequent bouts of pain, more anatomically diffuse and
longer-lasting pain than males with similar disease process-
es (Hurley and Adams, 2008). Animal research showing that
female rodents display a lower threshold in experimental
models of thermal, chemical, inflammatory and mechanical
nociception is consistent with the clinical data (for review see
Hurley and Adams, 2008). In contrast, stress-induced hyper-
algesia was comparable in male and female rats when
removed from the EPM. Female and male rats submitted to
vibration stress also display comparable hyperalgesia (Devall
et al., 2009).
Hyperalgesia was evident after the EPM whether rats were
tested with or without formalin injected into the paw. Rats
exposed to the eEPM or oEPM without prior administration of
formalin exhibited hyperalgesia on the hot plate test com-
pared to control rats kept in their home cage. Rats injected
with formalin also showed hyperalgesia on the hot plate test
following exposure to the oEPM. Experiment 2 extended these
findings to mice and demonstrated post-EPM hyperalgesia
with the formalin test. These findings indicate that it is the
environment and not the noxious effect of the formalin
injection that causes both the antinociception while on the
EPM and the hyperalgesia upon removal.
As shown in Fig. 4, oEPM-exposed mice exhibited anti-
nociception when compared to those exposed to the glass box
during the second phase (25–35 min after formalin) of the
formalin test. These results corroborate previous findings
showing that mice injected with formalin into the right hind
paw and exposed to the oEPM display antinociception
(Mendes-Gomes et al., 2011; Mendes-Gomes and Nunes-de-
Souza, 2005, 2009). However, during the 35–45-min interval
only mice kept in the oEPM (i.e., the oEPM-oEPM group)
displayed antinociception when compared to the control
group. Themagnitude of the antinociception begins to decrease
after approximately 20min of exposure to the oEPM although
this is difficult tomeasure given that the nociception associated
with the formalin test is greatly reducedat this time. In contrast,
moving mice from the oEPM to the glass box caused an
immediate loss of antinociception. These results suggest that
oEPM-induced antinociception is closely associated with the
aversive environment.
In conclusion, the present study shows rapid changes in
nociception depending on the environment. The antinocicep-
tion produced by the EPM disappears immediately after
removal. The shift occurs in both female and male rats, rats
and mice, and whether nociception is assessed with the hot
plate or formalin tests.
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4.1. Subjects
Subjects were adult male (210–285 g) and female (160–220 g)
Sprague–Dawley rats (Harlan, Kent WA, USA) and adult male
Swiss mice (25–35 g, Univ. Estadual Paulista-UNESP, SP, Brazil).
The rats were maintained under a reverse light/dark schedule
(lights off: 7:00 am) in a temperature controlled environment.
They were handled for 3–5 min for 3 consecutive days prior to
testing. Miceweremaintained under a 12 h light cycle (lights on
at 7:00 am) in a temperature (23±1 °C) and humidity (55±5%)
controlled environment. In all experiments, animals were
transported to the experimental room and left undisturbed for
at least 1 h prior to testing.
All procedures were conducted in accordance with National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. Efforts were made to minimize the number and
potential suffering of subjects. All experimental protocols
carried out with mice were analyzed and approved by the Sao
PauloStateUniversityResearchEthicsCommittee (CEP/FCF/Car.
protocol 43/2008). The studies using rats were approved by
the Animal Care and Use Committee at Washington State
University.
4.2. Apparatus and nociceptive tests
4.2.1. Enclosed and open elevated plus-mazes
The enclosed (eEPM) and the open (oEPM) elevated plus mazes
are modifications of the previously described standard
elevated plus maze (Lister, 1987; Pellow et al., 1985). They
comprise four enclosed (eEPM) or open arms (oEPM) connected
to a common central platform. The dimensions of these
apparatuses vary for rats and mice and are described in
Experiments 1 and 2, below. Themazewas thoroughly cleaned
with ethanol 20% between tests.
4.2.2. Hot plate test
The hot plate test was used in Experiment 1 to assess
nociception, as previously described (Morgan et al., 2006).
It consists of placing a rat on an enclosed square plate
(25.4×25.4 cm) heated to 52.5 °C. The latency for hind paw
licking, a supraspinally integrated response,wasmeasured. Rats
were removed from the hot plate if no response occurredwithin
50 s. Between subjects, the hot plate was thoroughly cleaned
with ethanol 20%.
4.2.3. Formalin test
Nociception during exposure to the EPM was assessed using
the formalin test. This test causes a biphasic nociceptive
response (Dubuisson and Dennis, 1977). The first phase
begins instantly after formalin injection and lasts approxi-
mately 5 min. It results from the direct stimulation of
nociceptors (Dubuisson and Dennis, 1977; McCall et al.,
1996). This phase was assessed in a glass (mice) or Plexiglas
(rats) box. The second phase begins approximately 20 min
after formalin injection, lasts approximately 40 min (Bon et
al., 2002) and involves C fiber activation (McCall et al., 1996;
Tjolsen et al., 1992). It is related to a period of sensitizationduring which an inflammatory process occurs (e.g., Le Bars et
al., 2001; Tjolsen et al., 1992). Rats andmicewere injectedwith
50 μl of formalin (formaldehyde 2.5% for mice and 0.925% for
rats) into the dorsal (for mice) or plantar surface (for rats) of
the right hind paw. The animal was placed in a glass
(30×20×25 cm) or Plexiglas (32×32×46) box to record the
duration of hind paw licking for the first 5 min following
administration of formalin. The second phase of the formalin
test was evaluated during 10 (Experiment 1: 25–35 min after
the formalin injection) or 30 min (Experiment 2: 25–55 min
after formalin injection) of exposure to the eEPM, oEPM or
glass box.
4.3. Procedure
4.3.1. Experiment 1: effect of EPM exposure on hot plate
latency
Enclosed (50×10×40 cm) and open (50×10×0.25 cm) elevated
plus mazes differed only in the height of the Plexiglas walls.
The four arms were connected to a common central platform
(10×10 cm) covered by a gray Plexiglas floor. The maze was
elevated 50 cm above floor level.
Naïve male (n=25, 8–9 per group) and female rats (n=24,
8 per group) were exposed to the eEPM or oEPM for 10 min and
then removed and immediately placed on the hot plate to
assess nociception. Non-EPM exposed control rats were
moved directly from their home cage to the hot plate
apparatus for testing. A few additional male rats were injected
with formalin (0.925%) into the plantar surface of the right
hind paw to insure that antinociception occurred during
exposure to the oEPM as reported previously (Cornélio and
Nunes-de-Souza, 2009; Mendes-Gomes et al., 2011; Mendes-
Gomes and Nunes-de-Souza, 2005, 2009). Immediately after
the injection rats were placed in a Plexiglas box and nocicep-
tion assessed for 5 min. Twenty-five minutes later, during the
second phase of the formalin test, rats either remained in the
Plexiglas box (control group; n=5) or were placed in the eEPM
(n=4) or oEPM (n=4) for 10 min. Time spent (in seconds) licking
the formalin injected paw was recorded. At the end of this
10 min of exposure the rat was placed on the hot plate to
assess nociception.
4.3.2. Experiment 2: assessment of formalin nociception in
mice following EPM exposure
Enclosed (30×5×15 cm) and open (30×5×0.25 cm) elevated
plus mazes for mice were used. The EPM consists of four arms
connected to a common central platform (5×5 cm) elevated
38.5 cm above floor level. The maze was constructed with
wood floors and transparent glass walls.
Male mice (n=9/group) were injected with formalin 2.5%
into the dorsal right hind paw and placed in a glass box
(30×20×25 cm; control situation) to record the time spent
licking the paw for 5 min (first phase of the formalin test).
Twenty-five minutes after the formalin injection, the second
phase of this nociceptive test was carried out in three different
conditions: the control group was exposed to the glass box
from25 to 55 min. A second groupwas exposed to the oEPM for
10 min (25–35 min) and returned to the glass box until the end
of the test (55 min). The final group was exposed to the oEPM
for the entire 25 to 55 min.
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All results were initially submitted to Levene's test for
homogeneity of variance. Non-homogeneous data were
transformed to square root and then submitted to analysis
of variance (ANOVA).
In Experiment 1, the hot plate latency data were analyzed
by two-way ANOVA (Factor 1: place of exposure; Factor 2: sex)
or Kruskal–Wallis ANOVA for non-parametrically distributed
data. Where indicated by significant F values, group differ-
enceswere identified by NewmanKeuls test (parametric) or by
Mann–Whitney U-tests (non-parametric).
In Experiment 2, results obtained during the first and
second phase of the formalin test were submitted to one-way
or two-way ANOVA for repeated measures (factor 1: place of
exposure; factor 2: interval, as dependent factor), respectively.
One-way ANOVA followed by Duncan test were used for
between-group comparisons. Planned comparisons were used
for within-group comparisons. In all cases, a P value of 0.05 or
less was required for significance.Acknowledgments
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